We are live on
!
Find out more
CNBT
Cornerstone National Bank & Trust Portfolio holdings
AUM
$296M
1-Year Est. Return
12.13%
This Fund
S&P 500
This Quarter
Est. Return
+3.41%
1 Year Est. Return
+12.13%
3 Year Est. Return
+33.95%
5 Year Est. Return
+27.34%
10 Year Est. Return
–
AUM
$229M
AUM Growth
+$15.5M
(+7.3%)
Cap. Flow
+$8.63M
Cap. Flow
% of AUM
3.78%
Top 10 Holdings %
Top 10 Hldgs %
77.18%
Holding
62
New
1
Increased
47
Reduced
5
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FlexShares Credit-Scored US Corporate Bond Index Fund
SKOR
|
+$3.3M |
| 2 |
FlexShares Credit-Scored US Long Corporate Bond Index Fund
LKOR
|
+$1.12M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$952K |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$742K |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$672K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$831K |
| 2 |
Allstate
ALL
|
+$694K |
| 3 |
FlexShares Disciplined Duration MBS Index Fund
MBSD
|
+$450K |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$174K |
| 5 |
Oracle
ORCL
|
+$4.54K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.65% |
| 2 | Financials | 2.05% |
| 3 | Healthcare | 1.97% |
| 4 | Consumer Discretionary | 1.54% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.65B
| $590K | 0.26% |
13,299
+713
| +6% | +$30.6K |
|
|
GTHX
52
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $549K | 0.24% |
25,000
| – | – |
|
53
Apple
AAPL
$4.57T
| $481K | 0.21% |
3,514
| – | – |
|
|
FMBI
54
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $473K | 0.21% |
23,843
| – | – |
|
55
iShares Russell 1000 Growth ETF
IWF
$128B
| $459K | 0.2% |
6,768
| – | – |
|
56
NVIDIA
NVDA
$5.42T
| $394K | 0.17% |
19,720
| – | – |
|
57
Edwards Lifesciences
EW
$51.7B
| $353K | 0.15% |
3,412
-16
| -0.5% | -$1.51K |
|
58
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $334K | 0.15% |
781
| – | – |
|
59
Baxter International
BAX
$14.2B
| $234K | 0.1% |
2,912
-53
| -2% | -$4.45K |
|
60
Verizon
VZ
$196B
| $229K | 0.1% |
4,082
+202
| +5% | +$11.6K |
|
|
61
Allstate
ALL
$67.5B
| – | – |
-6,036
| Closed | -$694K |
|
|
ALXN
62
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-5,434
| Closed | -$831K |
|
Similar funds
SM
FRA
CA
XSC
TOTUOP
CIC
RWPA
EP
Cornerstone National Bank & Trust's Q2 2021 Portfolio in Review
As of Q2 2021, Cornerstone National Bank & Trust held 62 positions worth $229M, up 7.3% from $213M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Cornerstone National Bank & Trust deployed $8.63M of net new capital in Q2 2021, opening 1 new position and adding to 47 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 7,769 shares worth $979K.
By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 4.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was FlexShares Disciplined Duration MBS Index Fund, an estimated $450K trimmed.
- Cornerstone National Bank & Trust's largest Q2 2021 buy was State Street Health Care Select Sector SPDR ETF: 7,769 shares worth $979K.
- Cornerstone National Bank & Trust added most to FlexShares Credit-Scored US Corporate Bond Index Fund in Q2 2021, an estimated $3.3M increase.
- Cornerstone National Bank & Trust's biggest Q2 2021 reduction was FlexShares Disciplined Duration MBS Index Fund, cutting an estimated $450K.
- Cornerstone National Bank & Trust fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $831K.
- Cornerstone National Bank & Trust's ten largest holdings make up 77% of its $229M portfolio in Q2 2021.
- Cornerstone National Bank & Trust opened 1 new position and closed 2 in Q2 2021.
- Cornerstone National Bank & Trust's portfolio value rose 7.3% quarter-over-quarter to $229M.
Based on Cornerstone National Bank & Trust's 13F filing for Q2 2021, filed 28 Jan 2026.